Form 4: Ormat Technologies Director Dafna Sharir Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Director Dafna Sharir reported transactions involving Ormat Technologies common stock and stock appreciation rights on August 23, 2024.

Summary

  • On August 23, 2024, Dafna Sharir, a director of Ormat Technologies, reported several transactions involving the company's common stock.
  • These transactions included the exercise of stock appreciation rights (SARs) and the subsequent sale of common stock.
  • Specifically, 1,621 SARs were exercised at a price of $53.16, resulting in the acquisition of 1,621 shares of common stock.
  • Sharir also disposed of 1,188 shares at $72.52 and 433 shares at $74.91.
  • Following these transactions, Sharir directly owns 3,561 shares of Ormat Technologies common stock.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common in publicly traded companies. It provides transparency to investors regarding the actions of company leadership.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.

Key Dates

DateDescription
11/07/2019Date Stock Appreciation Rights (SARs) were exercisable
08/23/2024Date of transactions: exercise of SARs and sale of common stock
11/07/2024Expiration date of Stock Appreciation Rights (SARs)
08/26/2024Date of signature on the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.